Grid Therapeutics

Last updated: April 17, 2024

Edward (Ned) Patz, CEO & Co-Founder
Edward (Ned) Patz, CEO & Co-Founder
Country: USA | Funding: $5M (+)

Website: https://gridtherapeutics.com

Grid is developing the first human derived targeted immunotherapy for cancer.